Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7781584
Dipeptidyl peptidase inhibitors
granted -
US 7781175
Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid
granted -
US 7777047
Indole compound
granted -
US 7767665
1,3-benzothiazinone derivatives and use thereof
granted -
US 7763716
Antibody against NPW
granted -
US 7754220
Methods of inhibiting secretion of follicle-stimulating hormone and testosterone
granted -
US 7754856
Human sodium-dependent bile acid transporter proteins
granted -
US 7750037
Antidepressant
granted -
US 7745623
Cyclic amide derivative, and its production and use
granted -
US 7737282
Benzimidazole compound crystal
granted -
US 7732626
Fused cyclic compounds
granted -
US 7732446
Dipeptidyl peptidase inhibitors
granted -
US 7723496
Preventives/remedies for cancer
granted -
US 7718798
Indole compound
granted -
US 7713973
Kinase inhibitors
granted -
US 7714009
Nitrogen-containing fused heterocyclic compounds
granted -
US 7700361
Secretory or membrane protein expressed in skeletal muscles
granted -
US 7700128
Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
granted -
US 7687625
Dipeptidyl peptidase inhibitors
granted -
US 7671174
Ligand to GPR8
granted -
US 7662974
Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
granted -
US 7662408
Sustained-release preparations
granted -
US 7662380
ZAQ ligand-1 antibodies and uses thereof
granted -
US 7659267
1,3-Benzothiazinone derivatives, process for producing the same use thereof
granted